Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment

Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment

Cytomegalovirus (CMV) reactivation has been linked to adverse clinical outcomes in critically ill patients, with emerging evidence suggesting a potential connection with severe COVID-19. Mechanisms driving this association may include primary lung injury, amplification of systemic inflammation, and...

Full description

Bibliographic Details
Main Authors: Georgios Schinas, Vasiliki Moustaka, Eleni Polyzou, Maria Panagiota Almyroudi, George Dimopoulos, Karolina Akinosoglou
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
cytomegalovirus infections
COVID-19
antiviral agents
intensive care units
SARS-CoV-2
CMV
Online Access:https://www.mdpi.com/1999-4915/15/5/1165

Internet

https://www.mdpi.com/1999-4915/15/5/1165

Similar Items